| Mesothelial cells in tissue repair and fibrosis SE Mutsaers, K Birnie, S Lansley, SE Herrick, CB Lim, CM Prêle Frontiers in pharmacology 6, 113, 2015 | 197 | 2015 |
| Empyema thoracis: new insights into an old disease FJH Brims, SM Lansley, GW Waterer, YCG Lee European Respiratory Review 19 (117), 220-228, 2010 | 141 | 2010 |
| Mesothelial cell differentiation into osteoblast‐and adipocyte‐like cells SM Lansley, RG Searles, A Hoi, C Thomas, H Moneta, SE Herrick, ... Journal of cellular and molecular medicine 15 (10), 2095-2105, 2011 | 85 | 2011 |
| The origin of regenerating mesothelium: a historical perspective SE Mutsaers, C Prêle, SM Lansley, SE Herrick The International Journal of Artificial Organs 30 (6), 484-494, 2007 | 51 | 2007 |
| Combination immune checkpoint blockade as an effective therapy for mesothelioma VS Fear, C Tilsed, J Chee, CA Forbes, T Casey, JN Solin, SM Lansley, ... Oncoimmunology 7 (10), e1494111, 2018 | 44 | 2018 |
| Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1–dependent mechanism SM Lansley, HM Cheah, JF Varano della Vergiliana, A Chakera, YCG Lee American Journal of Respiratory Cell and Molecular Biology 53 (1), 105-112, 2015 | 41 | 2015 |
| Malignant pleural fluid from mesothelioma has potent biological activities HM Cheah, SM Lansley, JF Varano della Vergiliana, AL Tan, R Thomas, ... Respirology 22 (1), 192-199, 2017 | 31 | 2017 |
| IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase C Jackaman, S Lansley, JE Allan, BWS Robinson, DJ Nelson International immunology 24 (6), 357-368, 2012 | 28 | 2012 |
| Human pleural fluid is a potent growth medium for Streptococcus pneumoniae ND Popowicz, SM Lansley, HM Cheah, ID Kay, CF Carson, GW Waterer, ... PLoS One 12 (11), e0188833, 2017 | 24 | 2017 |
| Role of MCP‐1 in pleural effusion development in a carrageenan‐induced murine model of pleurisy SM Lansley, HM Cheah, YCG Lee Respirology 22 (4), 758-763, 2017 | 19 | 2017 |
| Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells JF Varano della Vergiliana, SM Lansley, JM Porcel, S Bielsa, JS Brown, ... PloS one 8 (5), e63873, 2013 | 14 | 2013 |
| A commercially available preparation of Staphylococcus aureus bio‐products potently inhibits tumour growth in a murine model of mesothelioma SM Lansley, JF Varano della Vergiliana, AL Cleaver, SH Ren, A Segal, ... Respirology 19 (7), 1025-1033, 2014 | 12 | 2014 |
| Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis AL McGuire, SC Bennett, SM Lansley, ND Popowicz, ... PloS one 10 (3), e0119238, 2015 | 11 | 2015 |
| Mesothelial cells activate the plasma kallikrein-kinin system during pleural inflammation JF Varano della Vergiliana, S Lansley, AL Tan, J Creaney, YCG Lee, ... Walter de Gruyter 392 (7), 633-642, 2011 | 8 | 2011 |
| PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective MLO Morales, CA Rinaldi, E de Jong, SM Lansley, JPA Gummer, B Olasz, ... Iscience 25 (1), 2022 | 6 | 2022 |
| Streptococcus pneumoniae potently induces cell death in mesothelial cells R Rashwan, JF Varano della Vergiliana, SM Lansley, HM Cheah, ... Plos one 13 (7), e0201530, 2018 | 6 | 2018 |
| A subset of malignant mesothelioma tumors retain osteogenic potential SM Lansley, B Pedersen, C Robinson, RG Searles, G Sterrett, ... Scientific Reports 6 (1), 36349, 2016 | 3 | 2016 |
| Immunobiology of malignant mesothelioma AM Smith, S Lansley, C Lackman, B LKoloska, S Broomfield, ... Malignant Pleural Mesothelioma, 213-237, 2006 | 1 | 2006 |
| Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma ML Orozco Morales, CA Rinaldi, E de Jong, SM Lansley, YCG Lee, ... Plos one 18 (5), e0274364, 2023 | | 2023 |
| Human pleural fluid is a potent growth medium for Streptococcus pneumoniae YCGL Natalia D. Popowicz, Sally M. Lansley, Hui M. Cheah, Ian D. Kay ... PLOSone, 2017 | | 2017 |
